Trial reportScientific reports2025
The effect of barley savigh consumption on blood sugar among pre-diabetic postmenopausal women.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Smart assistive technologies for neurodisorders: A review on AI, IoT, and wearable systems for enhanced patient care.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The hormonal changes in menopause predispose women to health risks, including type 2 diabetes. Therefore, diabetes prevention in this age group is important. Considering the fewer side effects of herbal medicines compared to chemical drugs, the present study investigated the impact of barley savigh consumption on blood sugar levels in pre-diabetic postmenopausal women. This randomized clinical trial study was conducted on 64 pre-diabetic postmenopausal women referred to Community Health Centers in Gonabad city, Iran. The intervention group (n = 32) received 60 g of barley savigh daily (20 g before each meal), and the control group (n = 32) received no intervention. Fasting blood sugar (FBS) and blood sugar two hours post-prandial were checked in both groups at baseline and after two and four weeks. Data analysis was done using SPSS software (version 16) and chi-square, independent t-test, and Mann-Whitney tests at the significance level of p < 0.05. There was no significant difference in the mean FBS at baseline (109.31 ± 5.06 in the intervention and 109.03 ± 8.49 mg/dL in the control group, p = 0.904) and after two weeks after intervention (105.25 ± 5.92 in the intervention and 108.06 ± 8.75 mg/dL in the control group, p = 0.13), but the mean FBS after four weeks was significantly lower in the intervention (102.93 ± 7.75 mg/dL) compared to the control (107.90 ± 8.29 mg/dL) group (p = 0.019). The mean blood sugar two hours post-prandial was significantly lower in the intervention group compared to the control group after two (127.53 ± 8.03 and 143.68 ± 26.46 mg/dL, respectively, p = 0.006) and four weeks (127.09 ± 17.96 and 142.46 ± 27.06 mg/dL, respectively, p = 0.009). The results of the present study showed that barley savigh consumption could improve blood sugar regulation in pre-diabetic postmenopausal women.Trial registration: The present study was conducted as a randomized clinical trial. The study protocol was approved by the Iranian Registry of Clinical Trials (IRCT code 20200929048880N1). Registration date (25/10/2020).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.